Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial
Publication in refereed journal


引用次數
替代計量分析
.

其它資訊
摘要Background Resection of hepatocellular carcinoma is potentially curative, but local recurrence is common. In this prospective randomised trial, we aimed to find out if one dose of postoperative adjuvant intra-arterial iodine-131-labelled lipiodol could reduce the rate of local recurrence and increase disease-free and overall survival.
著者Lau WY, Leung TWT, Ho SKW, Chan M, Machin D, Lau J, Chan ATC, Yeo W, Mok TSK, Yu SCH, Leung NWY, Johnson PJ
期刊名稱Lancet
出版年份1999
月份3
日期6
卷號353
期次9155
出版社LANCET LTD
頁次797 - 801
國際標準期刊號0140-6736
電子國際標準期刊號1474-547X
語言英式英語
Web of Science 學科類別General & Internal Medicine; Medicine, General & Internal; MEDICINE, GENERAL & INTERNAL

上次更新時間 2021-18-09 於 00:36